Items

A Modified Approximate Internal Model-based Neural Control for the Typical Industrial Processes (2014-06)

J. Igić, M. Božić, A Modified Approximate Internal Model-based Neural Control for the Typical Industrial Processes, ELECTRONICS, Vol. 18, No. 1, pp. 46 - 53, Jun, 2014

Data-Driven Gradient Descent Direct Adaptive Control for Discrete-Time Nonlinear SISO Systems (2014-06)

Igor R. Krcmar, Miorad M. Bozic, Petar S. Maric, Data-Driven Gradient Descent Direct Adaptive Control for Discrete-Time Nonlinear SISO Systems, ELECTRONICS, Vol. 18, No. 1, pp. 39 - 45, Jun, 2014

Značaj humanih papiloma virusa u nastanku karcinoma glave i vrata (2016-04)

Ljiljana Božić, Sanja Jovičić, Aleksandra Šmitran, Značaj humanih papiloma virusa u nastanku karcinoma glave i vrata, SCRIPTA MEDICA, Vol. 47, No. 1, pp. 69 - 73, Apr, 2016

Prevalencija intrahospitalnih infekcija na hirurškim klinikama Univerzitetskog kliničkog centra Republike Srpske (2016-04)

J. Aćimović, S. Kunarac, N. Rodić Vukmir, LJ. Božić, LJ. Bojanić, Prevalencija intrahospitalnih infekcija na hirurškim klinikama Univerzitetskog kliničkog centra Republike Srpske, SCRIPTA MEDICA, Vol. 47, No. 1, pp. 34 - 41, Apr, 2016

Odgovor na terapiju mikofenolat mofetilom kod pacijentice sa teškim oblikom sistemskog eritemskog lupusa (2016-04)

LJ. Božić, B. Gašić, D. Jović, M. Vukčević, J. Aćimović, Odgovor na terapiju mikofenolat mofetilom kod pacijentice sa teškim oblikom sistemskog eritemskog lupusa, SCRIPTA MEDICA, Vol. 47, No. 1, pp. 77 - 78, Apr, 2016

Učestalost hidronefroze kod djece i adolescenata hospitalizovanih na Klinici za dječje bolesti Banja Luka (2016-06)

Sanja Jovičić, Snežana Petrović-Tepić, Ljiljana Božić, Duška Jović, Učestalost hidronefroze kod djece i adolescenata hospitalizovanih na Klinici za dječje bolesti Banja Luka, BIOMEDICINSKA ISTRAŽIVANjA, No. 1, pp. 21 - 26, Jun, 2016

Pharmacokinetics and Safety of Three Formulations of Rituximab (CT-P10, US-sourced Innovator Rituximab and EU-sourced Innovator Rituximab) in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks (2016-09)

C. Hee Suh, A. Berrocal Kasay, E. Chalouhi El-Khouri, P. Miranda, LJ. Božić, S. Jeka, P. Hrycaj, D. Rekalov, P. Wiland, A. Krause, I. Szombati, A. Mihailova, I. Hospodarskyy, M. Piotrowski, S. Ryul Kwon, E. Young Lee, D. Hyun Yoo, W. Park, S. Cheol Shim, S. Joon Lee, T. S. Kwon, Pharmacokinetics and Safety of Three Formulations of Rituximab (CT-P10, US-sourced Innovator Rituximab and EU-sourced Innovator Rituximab) in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks, STED Journal, pp. 100 - 101, Sep, 2016

Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks (2016-09)

W. Park, LJ. Božić, D. Milakovic, A. Berrocal Kasay, E. Chalouhi El-Khouri, F. Irazoque-Palazuelos, F. Fidencio Cons Molina, P. Shesternya, P. Miranda, F. G. Medina-Rodriguez, P. Wiland, S. Jeka, J. Chavez-Corrales, O. Garmish, T. Linde, D. Rekalov, P. Hrycaj, A. Krause, N. Fomina, O. Piura, M. Abello-Banfi, C. Hee Suh, S. Cheol Shim, S. Joon Lee, S. Young Lee, S. Hwan Kim, D. Hyun Yoo, Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks, STED Journal, pp. 100 - 101, Sep, 2016

Doprinos rolanja u učenju osnova alpskog skijanja (Contribution of inline skating to learning basics of alpine skiing) (2017-06)

I. Božić, V. Cigrovski, G. Bošnjak, V. Jakovljević, G. Tešanović, Doprinos rolanja u učenju osnova alpskog skijanja (Contribution of inline skating to learning basics of alpine skiing), SPORTLOGIA, Vol. 13, No. 1, pp. 1 - 8, Jun, 2017

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial (2017-07)

R. Fleischmann, E. Mysler, S. Hall, A. Kivitz, R. Moots, Z. Luo, R. DeMasi, K. Soma, R. Zhang, L. Takiya, S. Tatulych, C. Mojcik, S. Krishnaswami, S. Menon, J. Smolen, LJ. Božić, Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial, LANCET, THE, pp. 457 - 468, Jul, 2017

Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial (2018-08)

W. Park, LJ. Božić, D. Milakovic, A. Berrocal Kasay, E. El-Khouri, F. Irazoque-Palazuelos, F. Molina, P. Shesternya, P. Miranda, F. Medina-Rodriguez, Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial, STED Journal, pp. 934 - 943, Aug, 2018

Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial (2019-06)

S. Cheol Shim, LJ. Božić, A. Berrocal Kasay, E. Chalouhi El-Khouri, F. Irazoque-Palazuelos, F. Fidencio Cons Molina, F. G Medina-Rodriguez, P. Miranda, P. Shesternya, J. Chavez-Corrales, P. Wiland, S. Jeka, O. Garmish, P. Hrycaj, N. Fomina, W. Park, C. Hee Suh, S. Joon Lee, S. Young Lee, Y. Ju Bae, D. Hyun Yoo, Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial, RHEUMATOLOGY, pp. 2193 - 2202, Jun, 2019

Projektno orijentisan problemski zasnovan model učenja – prva iskustva u primeni modela u okviru studijskog programa Geodezija i geoinformatika (2020-01)

B. Božić, M. Pejić, S. Tucikešić, Projektno orijentisan problemski zasnovan model učenja – prva iskustva u primeni modela u okviru studijskog programa Geodezija i geoinformatika, TEHNIKA, Vol. 75, No. 1, pp. 23 - 30, Jan, 2020

NANOCOMPOSITE (CLAY BASED) AS A SUITABLE CARRIERS FOR BIOACTIVE MOLECULES: STABILITY AND ANTIMICROBIAL ASPECT (2021)

A. Šmitran, Lj. Božić, M. Đermanović, Lj. Bojanić, D. Jelić, NANOCOMPOSITE (CLAY BASED) AS A SUITABLE CARRIERS FOR BIOACTIVE MOLECULES: STABILITY AND ANTIMICROBIAL ASPECT, Journal of Hygienic Engineering and Design, Vol. 34, pp. 46 - 51, 2021

The comparison of SARS-CoV-2 antibody levels in medical personnel induced by different types of vaccines compared to the natural infection (2023)

Ljiljana Božić, Darija Knežević, Maja Travar, Nataša Miljuš, Miroslav Petković, Jela Aćimović, Jelena Djaković Dević, Miloš P. Stojiljković, Dejan Bokonjić, Ranko Škrbić, The comparison of SARS-CoV-2 antibody levels in medical personnel induced by different types of vaccines compared to the natural infection, CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 48, 2023